SMTI Sanara MedTech climbs 25 percent in daily trading despite Q4 2025 EPS landing below analyst estimates MEDP Medpace Holdings shares rise 435 percent after Q1 2026 EPS outpaces consensus analyst expectations What availability Investar ISTR Q1 2026 Profit Surprises